APPLICATION OF CARBAMAZEPINE AND OXCARBAZEPINE IN THE PREPARATION OF DRUGS TREATING PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMS

• 1. 含有氧阴离子基和/或其反应产物和分解产物的治疗药物及其应用于治疗帕金森氏病的用途 [P] . 中国专利： CN1222856A . 1999-07-14
• 2. 5-(4-羟基-3-甲氧基苯亚甲基)罗丹宁在制备治疗帕金森氏病药物中的用途 [P] . 中国专利： CN102670597B . 2014.07.09
• 3. APPLICATION OF CARBAMAZEPINE AND OXCARBAZEPINE IN THE PREPARATION OF DRUGS TREATING PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMS [P] . SK279645B6 . 1999-01-11

  机译： 卡马西平和奥卡西汀在治疗帕金森氏病和帕金森氏综合征的药物中的应用

• 4. APPLICATION OF CARBAMAZEPINE AND OXCARBAZEPINE IN THE TREATMENT OF PARKINSON'S DESEASE AND PARKINSONIAN SYNDROMS [P] . CA2153341A1 . 1994-07-21

  机译： 卡马西平和奥卡西汀在帕金森病和帕金森综合征中的应用

• 5. APPLICATION OF CARBAMAZEPINE AND OXCARBAZEPINE FOR PREPARATION PHARMACEUTICAL COMPOSITIONS SUITABLE TO THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES [P] . HUT72074A . 1996-03-28

  机译： 卡马西平和奥卡西汀在制备适合治疗帕金森氏病和帕金森氏综合征的药物中的应用

• 1. New drug treatments show neuroprotective effects in Alzheimer’s and Parkinson’s diseases [J] . Christian Hölscher 中国神经再生研究（英文版） . 2014,第021期
• 2. Manifestation of Pathological States of Numerous Diseases in the Largest Organ of the Human Body: (II) From Pancreatitis to Pancreatic Cancer Invasion, Formation of Stroma around the Primary Tumor in the Fascia, to Early Detection of Non-Coding microRNAs in Body Fluids and Development of Drugs to Treat Different Stages of Pancreatic Cancer [J] . Peter Chin Wan Fung, Regina Kit Chee Kong 临床医学国际期刊（英文） . 2020,第010期
• 3. Repurposing cancer drugs to treat neurological diseases – Src inhibitors as examples [J] . Da Zhi Liu 中国神经再生研究（英文版） . 2017,第006期
• 4. Differentiation of Parkinson's disease and non-Parkinsonian olfactory dysfunction with structural MRI data [C] . Jie Mei, Cecilia Tremblay, Nikola Stikov, Conference on Medical Imaging: Computer-Aided Diagnosis . 2021
• 5. Preparation, physicochemical properties and animal studies of new water-soluble prodrugs of carbamazepine and oxcarbazepine. [D] . Hemenway, Jeffrey N. 2006
• 6. A genome‐wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine [O] . Bianca Berghuis, Caragh Stapleton, Anja C. M. Sonsma, 2019
• 7. Simultaneous determination of topiramate, carbamazepine, oxcarbazepine and its major metabolite in human plasma by SFC-ESI-MS/MS with polarity switching: Application to therapeutic drug monitoring [O] . Wang Li, Wang Jingting, Zhang Jing, 2016

• 1. Studies of ATP sensitive potassium channels on 6 - hydroxydopamine and haloperidol rat models of Parkinson＇ s disease： Implications for treating Parkinson＇ s disease？ [J] . WANGSen ,YANGYong ,DINGJian-Hua . 中国药理通讯 . 2004,第002期
• 2. Treating inflammatory bowel disease by adsorptive leucocytapheresis:A desire to treat without drugs [J] . Abbi R Saniabadi ,Tomotaka Tanaka ,Toshihide Ohmori . 世界胃肠病学杂志：英文版 . 2014,第29期
• 3. CDS应用于帕金森氏病的治疗——多巴胺受体激动剂长效剂型的应用 [C] . 李又欣 . 2011年中国药学大会暨第11届中国药师周 . 2011
• 4. 中国北方汉族中3个帕金森氏病易感基因的SNPs与帕金森氏病的相关性及法医学意义 [A] . 朱兰卉 . 2013